Abstract

BackgroundCutaneous leishmaniasis (CL) is a neglected disease with a broad spectrum of clinical manifestations, ranging from small cutaneous nodules to severe mucosal tissue destruction. Leishmania (Viannia) braziliensis is the main species attributed to CL in the Americas. However, studies of experimental infection are limited in the murine model due to the self-resolutive pattern of the disease. Previously, our group demonstrated that the hamster model reproduces many of the clinical and histopathological features observed in humans. Herein, we standardized a RT-qPCR gene expression assay to evaluate a panel of immunological markers and a qPCR assay in order to quantify with high sensitivity and reproducibility the parasite load in skin lesions.MethodsHamsters were intradermally infected in the footpad with 105 promastigotes of L. (V.) braziliensis and 110 days post-infection skin lesions and popliteal lymph nodes were removed for RNA and DNA extraction, both from the same tissue fragment. Gene expression of IFN-ɣ, IL-10, TGF-β TNF, IL-4, IL-6, iNOS and arginase were measured using non-infected animal tissue as a calibrator. Parasite load was quantified from DNA extracted from lesions by qPCR targeting Leishmania kDNA and normalized by hamster GAPDH, using a SYBR Green-based absolute quantification methodology.ResultsA relative quantification RT-qPCR assay was standardized for the evaluation of mRNA levels from skin and lymph node samples of golden hamsters, with PCR efficiencies ranging from 92.3 to 116.4 %. In uninfected animals, higher basal mRNA levels in lymph nodes were observed for IFN-ɣ, TGF-β, TNF and IL-4 (111.4 ± 92.2; 5.6 ± 1.2; 5.3 ± 1.7; and 60.3 ± 26.8, respectively) in comparison to skin. In golden hamsters infected with L. (V.) braziliensis, an increase in the expression of all immunological markers evaluated was observed, ranging from 2.7 ± 0.2 for TGF-β to 1018.5 ± 809.0 for iNOS in skin lesions, and 2.4 ± 1.6 for TGF-β to 600.2 ± 666.4 for iNOS in popliteal lymph nodes. Interestingly, significantly higher levels of IFN-ɣ, TNF and IL-10 mRNA were observed in skin in comparison to lymph nodes, while a lower significant level of arginase mRNA was observed in skin. In parallel, parasite loads were quantified by qPCR from the skin lesions of infected animals, ranging from 27.0 to 6647.0, with a median of 553.4 (416.7–1504.0) parasites/mg skin equivalents, whereas lesion size varied from 0.3 to 3.1 mm. Despite the tendency of larger lesions to present higher parasite load, the correlation observed was not statistically significant.ConclusionsIn this study, we describe for the first time a sensitive, reproducible and cheaper molecular assay to quantify from the same tissue fragment the gene expression of immunological markers and the parasite load in skin lesions, observing a mixed profile of immune response in the hamster model infected by L. (V.) braziliensis.Electronic supplementary materialThe online version of this article (doi:10.1186/s13071-016-1647-6) contains supplementary material, which is available to authorized users.

Highlights

  • Cutaneous leishmaniasis (CL) is a neglected disease with a broad spectrum of clinical manifestations, ranging from small cutaneous nodules to severe mucosal tissue destruction

  • A relative quantification RT-Quantitative Real-Time PCR (qPCR) assay was standardized for the evaluation of mRNA levels from skin and lymph node samples of golden hamsters, with Polymerase chain reaction (PCR) efficiencies ranging from 92.3 to 116.4 %

  • Significantly higher levels of IFN-ɣ, Tumor necrosis factor (TNF) and Interleukin 10 (IL-10) mRNA were observed in skin in comparison to lymph nodes, while a lower significant level of arginase mRNA was observed in skin

Read more

Summary

Introduction

Cutaneous leishmaniasis (CL) is a neglected disease with a broad spectrum of clinical manifestations, ranging from small cutaneous nodules to severe mucosal tissue destruction. Our group demonstrated that the hamster model reproduces many of the clinical and histopathological features observed in humans. Despite numerous studies conducted in recent decades, there is still no vaccine licensed for use in humans and the treatment remains mostly based on pentavalent antimonials [4]. These data reinforce the need to investigate new drugs and vaccine candidates for the control and prophylaxis of CL. The golden hamster (Mesocricetus auratus) is the most susceptible model for the infection by species of the subgenus Viannia, reproducing many of the clinical and histopathological features observed in the human disease [8,9,10]. Few studies on drugs [12,13,14,15] and vaccines [16, 17] against CL are performed in the hamster model

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call